Close

Jump to:

  • Navigation
  • Content
  • Footer
TINCTURE London hero image

TINCTURE London

Follow

Detoxify your home with TINCTURE. Award-winning, 100% natural, non-toxic cleaning and wellbeing products.

129%
 - 
Funded 12 Nov 2021
£300,001 target
£395,080 from 234 investors
More
Less

Business overview

Location London, United Kingdom
Social media
Website www.tincturelondon.com
Sectors Home & Personal Mixed Digital/Non-Digital Mixed B2B/B2C
Company number 09016711
Incorporation date 29 Apr 2014
More
Less

Investment summary

Type Equity
Valuation (pre-money) £4.8M
Equity offered 7.45%
Share price £4.45
Tax relief

EIS

More
Less

Business highlights

  • 3 years R&D - proprietary formulations and packaging technology
  • £700,000+ total sales value. Launch DTC in 2020 +500% increase
  • Community of over 50k loyal customers and followers
  • Wholesale: QVC, Fenwick, Naturisimo, Farmdrop +200 inde retailers
More
Less

Key features

  • Secondary Market
  • Nominee investment min. £13.35 +
  • Direct investment min. £25,000.00 +
  • Idea
  • Key Information
  • Investor Rewards
  • Team
  • Updates
  • Investors 234
  • Discussion
  • Documents

Idea

Introduction

The air in a typical home is up to x5 more polluted than the air directly outside - the main culprit? Everyday household cleaning products. This is an environmental crisis which means that 93% of children breathe air that contains more pollutants than deemed safe (source: WHO)
TINCTURE is on a mission to fight indoor air pollution and revolutionise a $50bn industry
Our Products:
• Have been clinically tested and verified to perform equal or better than market leaders
• Kill 99.99% of bacteria and viruses, are dermatologically tested and environmentally safe
• Are uniquely formulated with no toxic ingredients - even “natural” ones
• Are made with pure essential oils, organic botanical extracts and plant-based actives – that’s it!
• Do not release harmful VOCs which impact indoor air quality
• Smell amazing and support essential wellbeing
• Look beautiful in antimicrobial bottles which use silver technology to keep them bacteria free, to be used and re-filled, safely, forever

Substantial accomplishments to date

• We conducted 3 years of extensive research and development in partnership with leading universities and research institutes to produce our proprietary formulations. TINCTURE products were inspired by ancient monastic wisdom but developed in partnership with scientific experts.

• We continue to work with research institutes and thought leaders on chemical load and indoor air quality including The INGENIOUS Project led by Professor Nicola Carslaw, University of York, The Royal College of Paediatrics and Child Health, and Airtopia.

• In 2020 the brand grew by + 500% and we have now reached over £700,000 in cumulative retail sales.

• We have been featured extensively in the UK media including Financial Times, The Guardian, The Telegraph, The Times, Vogue, Elle & Evening Standard amongst others

• Our wholesale business has built into 200+ key retailer partners across all selling channels that has grown our sales as well as our reach and awareness into new customer bases.

• We have received over a thousand of 5-star product reviews from our growing customer base

• We have fully developed 10x concentrated subscription formulations ready to launch which will transform our D2C business

• We have started our international expansion into Europe and Asia

Monetisation strategy

Our business model is simple, focused, and effective with 3 channels of distribution.

1) Direct-to-Consumer: Launched in 2020 & already accounts for over 70% of our sales. We have developed a strong consumer following with a community of over 50k, many of whom we will look to convert to our subscription service, generating exceptional life-time value.

2) Wholesale: TINCTURE wholesales with key retailers such as QVC & Fenwicks, major online sites, eco specialists and over 200 carefully selected, independent retailers. We also have a thriving B2B channel including yoga studios, spas and hospitality which significantly increase audience reach.

3) International: We are already expanding outside of the UK - have launched in Russia and are due to launch in S Korea, Taiwan, Hong Kong, Germany, Spain & Austria with further rollout planned across Europe, North America and key markets in Asia.

The potential for global growth is huge. This is a category worth almost $50 billion and growing at 8% CAGR.

Use of proceeds

Website: Updating our website, including the optimization of our subscription model, making TINCTURE more personalised to each customer's needs

Subscriptions: Launch of 10x concentrate letter box subscription format to maximise profitability and reduce our carbon footprint. Customers will benefit from our closed loop system allowing them to return everything for refill

Research & Development: To expand our product range into new categories including home, lifestyle and baby

Marketing: Activate an exciting marketing plan which will focus on Search, PPC, Paid Social, influencers & partnerships

Wholesale: Continue to build our wholesale network to extend the sales and reach of TINCTURE globally. Launch new product ranges into retail and support joint business plan activity with key partners

Key Information

Loan Disclosure

The company has a bounce back loan of £50,000 taken out from July 2020 to July 2026, with a 2.5% interest and repayment to begin after 12 months from the date of funds landing in the account.

Funds raised as part of this round will not be used to repay outstanding debt.

Investor Rewards

Open an account to get access to the team members of TINCTURE London

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for TINCTURE London has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 8 September 2021 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £4,836,928

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Nominee investment

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Nominee investment.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Nominee investment). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Security Token

A security token is a digital asset that represents ownership or other rights. It is a digital form of traditional investments. In the future, you may be able to trade your investment through compatible exchanges.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel